________________________________________________________________________________________________________________________________

(C) B2Bioworld 2012 - Joerg RiesmeierCash in Agbio and Food Markets

-Jörg Riesmeier, Direvo Industrial’s New COO on
near- to mid-term strategies

May 2010. After the bounty trade sale of Direvo’s pharmaceutical business line to Bayer Schering for €210m in 2008, investors hope to repeat such a profitable exit with remaining assets. Beginning 2010 shareholders pumped €6m into Direvo Industrial to bring them faster toward this goal. The firm’s pipeline offers attractive candidates, but will it have resources to turn these into products? Moreover, near-to-market developments have to be commercialised in agbio and food markets, both known not to lend itself to the pharma business model which management has successfully applied in the past. Jörg Riesmeier is expected to manage transition and position Direvo in rather unfamiliar markets against established biotech suppliers. In an updated interview the new COO describes to B2Bioworld his near- and mid-term strategies. Included in-house comparisons by Direvo of mannanase and phytase competitor products.

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)

Article free of advertisement - 4 pages
- Includes technical comparison with enzymes of competitors

Full Company License enquire here

Back to section

Related Editorial Articles

Bio-based economy? What's in it for business
An industry perspective and key trends in an emerging lead market

Direvo’s Claims to Process Lignocellulose to Lactic Acid
Comment on a Company Press Release

Plant Genetic Engineering:”It’s not as simple as Yes or No!”
Nobel Prize winner Christiane Nüsslein-Volhard Warns of GMO-populism and researchers not standing up. Exclusive interview for readers of B2Bioworld

Prospects of Enzyme Engineering and Biofuels Markets in Russia
Vladimir O. Popov, Director Bach Institute of Biochemistry, Moscow and EU liaison person

TALEs, Zinc Fingers, or Meganucleases
A Practice View from Crop Research and Breeding by Johan Botterman, Head of Product Research Bayer CropScience

Synthetic Genomics:
Autochthon Biotechnology

Business Strategies for Food, Feed, and Biofuels from Algae. James H Flatt, Chief Technology Officer Synthetic Genomics